Accent Therapeutics manages compounds across CROs with Xavo
Accent Therapeutics, a biopharmaceutical company in Lexington, Massachusetts, develops small-molecule cancer therapies targeting RNA modification. Much of its lab work runs through contract research organizations (CROs), so its compound inventory is spread across several partner sites.
This case study explores how Accent has used Xavo's cloud-based sample management since 2019 to keep one inventory of its small-molecule samples across all partners and to fulfil the sample orders that supply its scientists. In 2022, Accent upgraded to Xavo R3 to support its growing, distributed operations.
The upgrade reduced manual effort in executing sample orders and gave the sample-management team more confidence in the speed and precision of its workflow.
Download the full case study to discover how Accent Therapeutics keeps its compound inventory under control while working with multiple CROs.
At a glance
- Customer: Accent Therapeutics, biopharmaceutical company, Lexington, Massachusetts
- Focus: Small-molecule cancer therapies targeting RNA modification
- Challenge: A growing compound inventory held at several CROs
- Solution: Xavo, the cloud-based sample management platform from LabAthena
- Timeline: Xavo customer since 2019, upgraded to Xavo R3 in 2022
Questions this case study answers
How do you manage a compound inventory stored at several CROs?
Instead of reconciling spreadsheets from each partner, Accent keeps one cloud-based inventory in Xavo that covers every site, so the team always knows which compounds are stored where.
How do scientists get the compounds they need?
Scientists request samples in Xavo, and the sample-management team fulfils each order with the partner that holds the material. Every request is tracked from order to delivery.
Did the upgrade to Xavo R3 need custom development?
No. Accent's Xavo R3 setup was configured with standard, out-of-the-box functionality. The full case study describes the setup and the results for the sample-management team.
What the case study covers
The case study examines the challenge of managing a growing small-molecule inventory held at several CROs, and why spreadsheets and email stop scaling when compounds sit with multiple partners.
It explores how Xavo provides one inventory across all sites, how scientists request compounds and the sample-management team fulfils orders, and how the upgrade to Xavo R3 was configured using standard, out-of-the-box functionality.
The case study also outlines the results for the sample-management team and what other biotech companies working with CROs can take from Accent's approach.
Get the case study
Complete the form to receive “Accent Therapeutics Streamlines Compound Management Across CROs with Xavo” directly in your inbox.